Skip to main content
Gujarat Ambuja Exports Ltd. logo

Gujarat Ambuja Exports Ltd. — Investor Relations & Filings

Ticker · GAEL ISIN · INE036B01030 LEI · 335800M9TVMR5FIXZ129 BSE.NS Manufacturing
Open in API
Filings indexed 966 across all filing types
Latest filing 2021-10-30 Regulatory Filings
Country IN India
Listing BSE.NS GAEL

About Gujarat Ambuja Exports Ltd.

https://www.ambujagroup.com

Gujarat Ambuja Exports Ltd. is an agro-processing organization specializing in the manufacturing of corn-based starch derivatives, soy products, and cotton yarn. The company operates integrated processing facilities to produce liquid glucose, sorbitol, maltodextrin, and dextrose monohydrate, serving the food, pharmaceutical, and paper sectors. Its soy division focuses on de-oiled cakes, refined soy oil, and lecithin for the animal feed and human nutrition markets. GAEL maintains an extensive global export footprint, providing high-volume industrial ingredients that meet international quality standards. The company leverages large-scale production capabilities to supply diverse applications in the textile and healthcare industries, emphasizing efficiency and consistency across its product portfolio.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for omitted pictures and no textual content or financial data. It is extremely short (174 characters) and does not contain any report, announcement, or regulatory information. Given the lack of content, it cannot be classified as a substantive report or announcement. Therefore, it falls under the fallback category of Regulatory Filings (RNS).
2021-10-30 English
Financial Results Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed communication from the Board of Directors of Gujarat Ambuja Exports Limited dated 30th October 2021. It announces the approval of unaudited standalone and consolidated financial results for the second quarter and half year ended 30th September 2021. The document includes detailed financial data such as income from operations, expenses, profit before tax, tax expense, and net profit for the period, along with other comprehensive income items. The presence of substantive financial data and analysis for a period shorter than a full fiscal year (quarter and half year) indicates this is an Interim / Quarterly Report. The document is not merely an announcement or a certification but contains actual financial statements and results. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2021-10-30 English
Financial Result Updates
Regulatory Filings
2021-10-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (370 characters) and contains no substantive text or financial data, only placeholders for images and a partial table with dates and fund names. There is no indication of a full report, financial statements, or detailed information. It appears to be a fragment or a placeholder rather than a full filing. Given the lack of content and the presence of minimal data, this document does not fit any detailed report category. It is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous or incomplete filings.
2021-10-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a notification about the schedule of analyst and institutional investor meetings. It explicitly states that no presentations or unpublished price sensitive information will be shared. The content is an announcement of upcoming meetings rather than a report or transcript of the meetings themselves. It does not contain financial data, detailed presentations, or transcripts. Therefore, it fits best under the category of Investor Presentation (IP) announcements or related meeting notifications. However, since it specifically states no presentations will be made and is simply an intimation of meeting schedules, it is not a full investor presentation document. Given the options, the closest classification is Regulatory Filings (RNS) as a general regulatory announcement about meetings, since it does not fit the detailed investor presentation category (IP) or call transcript (CT). The document length is short and it is an announcement, not a report or transcript.
2021-10-20 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document text is extremely short (609 characters) and contains references to stock exchange listing departments and security codes, but no substantive financial data, report content, or detailed disclosures. It appears to be a brief communication or notice related to stock exchange listing or market operations, without any detailed report or financial statements. There is no indication of an actual report, audit, earnings release, or other detailed filing. Given the brevity and nature, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.